Filing Details
- Accession Number:
- 0001209191-23-057053
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-01 13:38:01
- Reporting Period:
- 2023-11-29
- Accepted Time:
- 2023-12-01 13:38:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1662774 | Quince Therapeutics Inc. | QNCX | Biological Products, (No Disgnostic Substances) (2836) | 901024039 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1770790 | David Lamond | C/O Quince Therapeutics, Inc. 601 Gateway Blvd, Ste. Suite 1250 South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-11-29 | 14,378 | $0.98 | 2,193,539 | No | 4 | P | Indirect | By Blue Devil Trust dated 12/03/2010 |
| Common Stock | Acquisiton | 2023-11-30 | 14,378 | $0.90 | 2,207,917 | No | 4 | P | Indirect | By Blue Devil Trust dated 12/03/2010 |
| Common Stock | Acquisiton | 2023-12-01 | 14,378 | $0.94 | 2,222,295 | No | 4 | P | Indirect | By Blue Devil Trust dated 12/03/2010 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Blue Devil Trust dated 12/03/2010 |
| No | 4 | P | Indirect | By Blue Devil Trust dated 12/03/2010 |
| No | 4 | P | Indirect | By Blue Devil Trust dated 12/03/2010 |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 301,829 | Direct | |
| Common Stock | 1,734,722 | Indirect | By David A. Lamond Trust dated 2006 |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.95 to $0.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
- Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the "Trust") and holds sole voting and dispositive power with respect to the shares held of record by the Trust.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.90 to $0.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.91 to $0.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
- Mr. Lamond is the trustee of David A. Lamond Trust dated 2006 (the "2006 Trust") and holds sole voting and dispositive power with respect to the shares held of record by the 2006 Trust.
Billionaire Hedge Funds
